CAPOX	Capecitabine and Oxaliplatin
CEA	Carcinoembryonic Antigen
cCR	Clinical Complete Response
CI	Confidence Interval
cN	Clinical Nodal Stage
COPD	Chronic Obstructive Pulmonary Disease
CRM	Circumferential Resection Margin
CT	Computed Tomography
cT	Clinical Tumor Stage
cT4	Clinical T4 Stage
DWI	Diffusion-Weighted Imaging
EMVI	Extramural Venous Invasion
FOLFOX	Fluorouracil, Leucovorin, and Oxaliplatin
HR	Hazard Ratio
IMRT	Intensity-Modulated Radiotherapy
IQR	Interquartile Range
LARC	Locally Advanced Rectal Cancer
LCCRT	Long-Course Chemoradiotherapy
mFOLFIRINOX	Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin
MRI	Magnetic Resonance Imaging
MRF	Mesorectal Fascia
OR	Odds Ratio
pCR	Pathological Complete Response
RMST	Restricted Mean Survival Time
SD	Standard Deviation
TME	Total Mesorectal Excision
TNT	Total Neoadjuvant Therapy
VMAT	Volumetric-Modulated Arc Therapy
ypT0N0	Absence of viable residual tumor in the rectal wall and regional lymph nodes (Pathological Complete Response)